Recognition and Handling of Discordant Negative Human Epidermal Growth Factor Receptor 2 Classification by Oncotype DX in Patients With Breast Cancer

被引：8

作者：

Christgen, Matthias ^{[1
]}

Harbeck, Nadia ^{[2
,3
]}

Gluz, Oleg ^{[2
]}

Nitz, Ulrike ^{[2
]}

Kreipe, Hans H. ^{[1
]}

机构：

[1] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany

[2] W German Study Grp, Monchengladbach, Germany

[3] Univ Munich, Munich, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 26期

关键词：

D O I：

10.1200/JCO.2012.42.1990

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：3313 / 3314

页数：3

共 4 条

[1]

High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study [J].

Dabbs, David J. ;

Klein, Molly E. ;

Mohsin, Syed K. ;

Tubbs, Raymond R. ;

Shuai, Yongli ;

Bhargava, Rohit .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4279-4285

[2]

Degenhardt T, 2011, J CLIN ONCOL S15, V29, p653s

[3]

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches [J].

Lehmann-Che, J. ;

Amira-Bouhidel, F. ;

Turpin, E. ;

Antoine, M. ;

Soliman, H. ;

Legres, L. ;

Bocquet, C. ;

Bernoud, R. ;

Flandre, E. ;

Varna, M. ;

de Roquancourt, A. ;

Plassa, L-F ;

Giacchetti, S. ;

Espie, M. ;

de Bazelaire, C. ;

Cahen-Doidy, L. ;

Bourstyn, E. ;

Janin, A. ;

de The, H. ;

Bertheau, P. .

BRITISH JOURNAL OF CANCER, 2011, 104 (11) :1739-1746

[4]

Schmitt M, 2011, EXPERT REV MOL DIAGN, V11, P617, DOI [10.1586/erm.11.47, 10.1586/ERM.11.47]

← 1 →